<DOC>
	<DOCNO>NCT00423878</DOCNO>
	<brief_summary>The study compare effectiveness antipsychotic medication patient schizophrenia schizoaffective disorder medication change may indicate increase risk cardiovascular disease .</brief_summary>
	<brief_title>Comparison Antipsychotics Metabolic Problems Schizophrenia Schizoaffective Disorder</brief_title>
	<detailed_description>Metabolic abnormality associate cardiovascular morbidity premature mortality common patient schizophrenia match control . Although evidence patient schizophrenia intrinsic abnormality lipid carbohydrate metabolism , antipsychotic ( i.e. , clozapine , olanzapine , quetiapine , risperidone ) associate increase rate metabolic abnormality predispose patient cardiovascular disease . This investigator-initiated clinical trial conduct 30 research site part NIMH Schizophrenia Trials Network . The aim study ( 1 ) determine relative effect switch aripiprazole , versus continue treatment olanzapine , quetiapine , risperidone , metabolic parameter associate cardiovascular disease , ( 2 ) determine effect switch aripiprazole versus continue treatment olanzapine , quetiapine , risperidone clinical stability schizophrenic illness . This study design multi-site , single-blind ( rater ) randomize control trial 300 patient schizophrenia schizoaffective disorder compare treatment follow medication : olanzapine , quetiapine , risperidone , aripiprazole . The study enroll patient schizophrenia schizoaffective disorder medication change may indicate increase risk cardiovascular disease spite adequate control symptom current antipsychotic medication . Patients take olanzapine , quetiapine , risperidone body-mass index ( BMI ) great equal 27 non-HDL cholesterol great equal 130 mg/dl eligible ( non-HDL 130-139mg/dL , LDL cholesterol must great 100mg/dL ) . All treatment open label . Raters blind treatment assignment . Patients follow 6 month .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Diagnosed schizophrenia schizoaffective disorder Currently treat olanzapine , quetiapine risperidone BMI great equal 27 NonHDL cholesterol great equal 130 mg/dL ( nonHDL cholesterol 130 139 mg/dL , LDL cholesterol must great 100 mg/dL ) . Diabetes ( FBS great equal 126 ) treatment oral hypoglycemic drug insulin NonHDL cholesterol great 300 mg/dL Serum triglycerides great 500 mg/dL Patients first episode schizophrenia schizoaffective disorder Known hypersensitivity aripiprazole On weight loss medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2010</verification_date>
</DOC>